Free Trial

Encompass Health (EHC) Stock Price, News & Analysis

$91.64
+1.00 (+1.10%)
(As of 07/26/2024 ET)
Today's Range
$90.80
$91.96
50-Day Range
$83.47
$91.64
52-Week Range
$57.55
$91.96
Volume
573,000 shs
Average Volume
629,622 shs
Market Capitalization
$9.23 billion
P/E Ratio
24.77
Dividend Yield
0.65%
Price Target
$96.50

Encompass Health MarketRank™ Stock Analysis

Analyst Rating
Buy
3.20 Rating Score
Upside/​Downside
5.3% Upside
$96.50 Price Target
Short Interest
Healthy
1.86% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-0.71
Upright™ Environmental Score
News Sentiment
0.98mentions of Encompass Health in the last 14 days
Based on 10 Articles This Week
Insider Trading
Selling Shares
$5.82 M Sold Last Quarter
Proj. Earnings Growth
11.25%
From $4.09 to $4.55 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.95 out of 5 stars

Medical Sector

13th out of 936 stocks

Hospitals Industry

1st out of 3 stocks

EHC stock logo

About Encompass Health Stock (NYSE:EHC)

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. The company was incorporated in 1984 and is based in Birmingham, Alabama.

EHC Stock Price History

EHC Stock News Headlines

Barclays Keeps Their Buy Rating on Encompass Health (EHC)
“Generational Bull Run” Incoming
LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.
“Generational Bull Run” Incoming
LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.
See More Headlines
Receive EHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Encompass Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
4/24/2024
Ex-Dividend for 7/15 Dividend
7/01/2024
Dividend Payable
7/15/2024
Today
7/26/2024
Next Earnings (Confirmed)
8/05/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Hospitals
Sub-Industry
Health Care Facilities
CUSIP
42192430
Employees
38,000
Year Founded
1984

Price Target and Rating

Average Stock Price Target
$96.50
High Stock Price Target
$113.00
Low Stock Price Target
$80.00
Potential Upside/Downside
+5.3%
Consensus Rating
Buy
Rating Score (0-4)
3.20
Research Coverage
10 Analysts

Profitability

Net Income
$352 million
Pretax Margin
12.90%

Debt

Sales & Book Value

Annual Sales
$4.80 billion
Cash Flow
$6.71 per share
Book Value
$22.50 per share

Miscellaneous

Free Float
98,571,000
Market Cap
$9.23 billion
Optionable
Optionable
Beta
0.89

Social Links

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report

EHC Stock Analysis - Frequently Asked Questions

How have EHC shares performed this year?

Encompass Health's stock was trading at $66.72 at the start of the year. Since then, EHC shares have increased by 37.3% and is now trading at $91.61.
View the best growth stocks for 2024 here
.

How were Encompass Health's earnings last quarter?

Encompass Health Co. (NYSE:EHC) announced its quarterly earnings results on Wednesday, April, 24th. The company reported $1.12 EPS for the quarter, topping analysts' consensus estimates of $0.93 by $0.19. The firm's revenue for the quarter was up 13.4% compared to the same quarter last year.

What is Mark Tarr's approval rating as Encompass Health's CEO?

231 employees have rated Encompass Health Chief Executive Officer Mark Tarr on Glassdoor.com. Mark Tarr has an approval rating of 79% among the company's employees.

Does Encompass Health have any subsidiaries?

Encompass Health subsidiaries include Baptist Outpatient Services Inc., Frontier Home Health and Hospice, Generation Solutions of Lynchburg LLC, Alacare Home Health & Hospice, Camellia Healthcare, CareSouth Health System Inc., Reliant Hospital Partners LLC, and others.

Who are Encompass Health's major shareholders?

Top institutional shareholders of Encompass Health include Bank of New York Mellon Corp (1.50%), Sumitomo Mitsui Trust Holdings Inc. (1.02%), Reinhart Partners LLC. (0.65%) and Van Lanschot Kempen Investment Management N.V. (0.58%). Insiders that own company stock include Mark J Tarr, Douglas E Coltharp, John Patrick Darby, Elissa Joy Charbonneau, Greg D Carmichael, Kevin J O'connor and Terrance Williams.
View institutional ownership trends
.

How do I buy shares of Encompass Health?

Shares of EHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Encompass Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Encompass Health investors own include Salesforce (CRM), Johnson & Johnson (JNJ), Alibaba Group (BABA), CVS Health (CVS), Intel (INTC), NVIDIA (NVDA) and Cisco Systems (CSCO).

This page (NYSE:EHC) was last updated on 7/26/2024 by MarketBeat.com Staff

From Our Partners